Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infants

Cell Host Microbe. 2022 Jan 12;30(1):110-123.e5. doi: 10.1016/j.chom.2021.12.002. Epub 2021 Dec 20.

Abstract

Rotavirus vaccines (RVVs) have substantially diminished mortality from severe rotavirus (RV) gastroenteritis but are significantly less effective in low- and middle-income countries (LMICs), limiting their life-saving potential. The etiology of RVV's diminished effectiveness remains incompletely understood, but the enteric microbiota has been implicated in modulating immunity to RVVs. Here, we analyze the enteric microbiota in a longitudinal cohort of 122 Ghanaian infants, evaluated over the course of 3 Rotarix vaccinations between 6 and 15 weeks of age, to assess whether bacterial and viral populations are distinct between non-seroconverted and seroconverted infants. We identify bacterial taxa including Streptococcus and a poorly classified taxon in Enterobacteriaceae as positively correlating with seroconversion. In contrast, both bacteriophage diversity and detection of Enterovirus B and multiple novel cosaviruses are negatively associated with RVV seroconversion. These findings suggest that virome-RVV interference is an underappreciated cause of poor vaccine performance in LMICs.

Keywords: bacteriophage; immunization; metagenomic sequencing; microbiome; microbiota; phageome; rotavirus vaccine performance; transkingdom interaction; vaccination; viral bacterial co-infection.

MeSH terms

  • Bacteria / classification
  • Bacteriophages
  • Cohort Studies
  • Coinfection
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome
  • Ghana
  • Humans
  • Immunization
  • Infant
  • Intestine, Small / virology*
  • Male
  • Metagenome
  • Rotavirus / physiology*
  • Rotavirus Infections / immunology*
  • Rotavirus Infections / virology
  • Rotavirus Vaccines
  • Seroconversion
  • Vaccination
  • Vaccines, Attenuated
  • Virome / physiology*

Substances

  • RIX4414 vaccine
  • Rotavirus Vaccines
  • Vaccines, Attenuated